A detailed history of Becker Capital Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Becker Capital Management Inc holds 1,957 shares of NVO stock, worth $169,123. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,957
Previous 2,347 16.62%
Holding current value
$169,123
Previous $335,000 30.45%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $46,437 - $56,713
-390 Reduced 16.62%
1,957 $233,000
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $46,460 - $61,843
-455 Reduced 16.24%
2,347 $301,000
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $28,967 - $34,798
-330 Reduced 10.54%
2,802 $289,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $142,412 - $312,479
1,566 Added 100.0%
3,132 $284,000
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $244,264 - $270,369
1,566 New
1,566 $253,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Becker Capital Management Inc Portfolio

Follow Becker Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.